Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon, BSP Enter Cyto-Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Patheon, BSP Enter Cyto-Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon has entered a sales and marketing agreement with Italy’s BSP Pharmaceuticals, a developer and manufacturer of cytotoxic pharmaceutical products. Patheon will promote BSP’s cytotoxic manufacturing capacity and development services and Aldo Braca, president, Patheon Europe, will serve as president and chief executive officer of BSP Pharmaceuticals until a successor is named. For a transitional period, Mr. Braca will fill both roles.
   
“Cytotoxic manufacturing represents a major market opportunity, and a capability that Patheon does not have in its network. With these agreements in place, Patheon can now offer its clients a complete suite of services — which now includes cytotoxics — in contract manufacturing and formulation development,” said Wes Wheeler, chief executive officer and president.
   
Cytotoxic products play a significant role in the oncology market, which is estimated to be approximately $9.6 billion and is expected to reach $12.8 billion by 2009.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics